Protocol for a prospective, single-arm pilot trial assessing the clinical and supraspinal neural effects of non-invasive transcranial neuromodulation in adults with overactive bladder
Contemporary Clinical Trials Communications · 2026-12 · 54 · 101680
DOI: 10.1016/j.conctc.2026.101680 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Contemporary Clinical Trials Communications, 2026-12. Verfasst von Betsy H Salazar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Houston Methodist Hospital, 6560 Fannin St., Suite 2100, Houston, TX, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Houston Methodist Academic Institute.
Abstract (Originalsprache)
Background
Overactive bladder (OAB) is a prevalent condition characterized by urinary urgency, frequency, and nocturia, with or without urge urinary incontinence. It significantly affects quality of life and is associated with increased rates of depression and sexual dysfunction. Lower urinary tract (LUT) control relies on coordinated activity across peripheral, spinal, and supraspinal networks. Individuals with OAB exhibit abnormal supraspinal network activity. Current treatments primarily target peripheral pathways and have limited efficacy. Repetitive transcranial magnetic stimulation (rTMS) offers a non-invasive approach to modulate networks involved in LUT control.
Methods
This prospective, single-center, single-arm, pilot trial evaluates the clinical and neural effects of neuronavigated rTMS in individuals with OAB. Baseline functional MRI (fMRI) guides individualized targeting of OAB-relevant regions. Participants undergo five sessions of low-frequency stimulation of the pelvic supplementary motor area (SMA) followed by high-frequency rTMS to the dorsolateral prefrontal cortex (DLPFC). Primary endpoints are changes in LUT control network functional connectivity (FC) during full and empty bladder conditions. Secondary outcomes include changes in OAB symptoms, urinary frequency and incontinence episodes, quality of life, and patient-perceived bladder condition. Pelvic floor muscle (PFM) electromyography (EMG) recorded during the first and fifth sessions provides exploratory physiological outcomes. Clinical outcomes are assessed immediately, three and six weeks post-treatment.
Discussion
This study is the first to evaluate non-invasive neuromodulation of supraspinal regions in individuals with OAB. By targeting brain networks involved in LUT control, this neuronavigated approach may improve FC and provide a novel therapeutic strategy for individuals with OAB refractory to conventional treatments. Trial registration number: NCT06198439. Participant enrollment and follow-up have been completed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Houston Methodist Hospital, 6560 Fannin St., Suite 2100, Houston, TX, USA.
- Texas A&M College of Medicine, Houston, TX, USA.
- Department of Obstetrics and Gynecology, Houston Methodist Hospital, 6550 Fannin St., Suite 2221, Houston, TX, USA.
Förderung
- Houston Methodist Academic Institute
Zitieren
APA
Salazar, B. H., Colbert, K., Hoffman, K. A., Khavari, R., & High, R. A. (2026). Protocol for a prospective, single-arm pilot trial assessing the clinical and supraspinal neural effects of non-invasive transcranial neuromodulation in adults with overactive bladder. Contemporary Clinical Trials Communications, 54, 101680. https://doi.org/10.1016/j.conctc.2026.101680
Vancouver
Salazar BH, Colbert K, Hoffman KA, Khavari R, High RA. Protocol for a prospective, single-arm pilot trial assessing the clinical and supraspinal neural effects of non-invasive transcranial neuromodulation in adults with overactive bladder. Contemporary Clinical Trials Communications. 2026;54:101680. doi:10.1016/j.conctc.2026.101680
BibTeX
@article{Salazar2026,
author = {Salazar, Betsy H and Colbert, Kevin and Hoffman, Kristopher A and Khavari, Rose and High, Rachel A},
title = {Protocol for a prospective, single-arm pilot trial assessing the clinical and supraspinal neural effects of non-invasive transcranial neuromodulation in adults with overactive bladder},
journal = {Contemporary Clinical Trials Communications},
year = {2026},
volume = {54},
pages = {101680},
doi = {10.1016/j.conctc.2026.101680}
}
EUVIMED